Deniz Cansen Kahraman
Deniz Cansen Kahraman
Verified email at metu.edu.tr
Title
Cited by
Cited by
Year
Near‐IR absorbing BODIPY derivatives as glutathione‐activated photosensitizers for selective photodynamic action
IS Turan, FP Cakmak, DC Yildirim, R Cetin‐Atalay, EU Akkaya
Chemistry–A European Journal 20 (49), 16088-16092, 2014
742014
Application of the Ugi reaction with multiple amino acid-derived components: synthesis and conformational evaluation of piperazine-based minimalist peptidomimetics
M Stucchi, S Cairati, R Cetin-Atalay, MS Christodoulou, G Grazioso, ...
Organic & Biomolecular Chemistry 13 (17), 4993-5005, 2015
232015
Phase and tv based convex sets for blind deconvolution of microscopic images
M Tofighi, O Yorulmaz, K Köse, DC Yıldırım, R Çetin-Atalay, AE Cetin
IEEE Journal of Selected Topics in Signal Processing 10 (1), 81-91, 2015
222015
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics
MMA Hawash, DC Kahraman, F Eren, RC Atalay, SN Baytas
European Journal of Medicinal Chemistry 129, 12-26, 2017
212017
Ynamide Click chemistry in development of triazole VEGFR2 TK modulators
M Vojtičková, J Dobiaš, G Hanquet, G Addová, R Cetin-Atalay, ...
European journal of medicinal chemistry 103, 105-122, 2015
112015
Contrast enhancement of microscopy images using image phase information
S Cakir, DC Kahraman, R Cetin-Atalay, AE Cetin
IEEE Access 6, 3839-3850, 2018
102018
Targeting PI3K/Akt/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment
DC Kahraman, T Kahraman, R Cetin-Atalay
Molecular Cancer Therapeutics 18 (11), 2146-2157, 2019
72019
Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine—(thio) urea hybrids as potential kinase inhibitors
A Türe, DC Kahraman, R Cetin-Atalay, S Helvacıoğlu, M Charehsaz, ...
Computational biology and chemistry 78, 227-241, 2019
52019
Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells
DC Kahraman, G Hanquet, L Jeanmart, S Lanners, P Šramel, A Boháč, ...
Medchemcomm 8 (1), 81-87, 2017
42017
Design, synthesis and biological evaluation of novel 1, 3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents
N Inceler, Y Ozkan, NN Turan, DC Kahraman, R Cetin-Atalay, SN Baytas
MedChemComm 9 (5), 795-811, 2018
32018
Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib
DC Kahraman, T Kahraman, RC Atalay
bioRxiv, 306910, 2018
22018
CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation
G Ayaz, N Razizadeh, P Yaşar, G Kars, DC Kahraman, Ö Saatci, Ö Şahin, ...
Scientific reports 10 (1), 1-14, 2020
12020
Author Correction: CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation
G Ayaz, N Razizadeh, P Yaşar, G Kars, DC Kahraman, Ö Saatci, Ö Şahin, ...
Scientific Reports 10 (1), 1-1, 2020
2020
Author Correction: CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation
A Gamze, R Negin, Y Pelin, K Gizem, DC Kahraman, S Özge, Ş Özgür, ...
Scientific Reports (Nature Publisher Group) 10 (1), 2020
2020
A NEW THIADIAZINE DERIVATIVE INDUCES OXIDATIVE STRESS DEPENDENT CELL DEATH IN HEPATOCELLULAR CARCINOMA STEM CELLS
DC Kahraman, EB Guven, P Aytac, B Tozkoparan, RC Atalay
HEPATOLOGY 70, 1108A-1108A, 2019
2019
A new thiadiazine derivative induces oxidative stress dependent JNK pathway activation and cell death in hepatocellular carcinoma
DC Kahraman, EB Guven, B Tozkoparan, RC Atalay
Cancer Research 79 (13 Supplement), 995-995, 2019
2019
In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma
E Sinoplu, N Tuncbag, DC Kahraman, RC Atalay
Cancer Research 79 (13 Supplement), 996-996, 2019
2019
OP-005. Effects of small molecule inhibitors on liver cancer stem cells in comparison with Sorafenib
DC Kahraman, RÇ Atalay
The Turkish Journal of Gastroenterology 30 (supp1), S7, 2019
2019
Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine—(thio) urea hybrids as potential kinase inhibitors
İ Küçükgüzel, M Charehsaz, S Helvacıoğlu, R Cetin-Atalay, DC Kahraman, ...
2019
Abstract LB-A08: Differential alteration of IL-8 in response to Sorafenib and PI3K/Akt/mTOR inhibitors in liver cancer cells and in liver cancer stem cells
DC Kahraman, RC Atalay
Molecular Cancer Therapeutics 17 (1 Supplement), LB-A08-LB-A08, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20